FDA Panel to Consider Pain Indication for Antidepressant
Posted on 17. Aug, 2010 by Dr. Ellis in News and Updates
WASHINGTON (MedPage Today) — An FDA advisory committee will meet later this week to review whether the antidepressant duloxetine (Cymbalta) should be used as a treatment for chronic pain despite risks that include liver damage and skin disease.
Read Full Article…
Possibly Related Blogs
FDA Panel Says Yes to Epilepsy Drug
Posted on 11. Aug, 2010 by Dr. Ellis in News and Updates
(MedPage Today) — SILVER SPRING, Md. — An FDA advisory committee voted 13-0 Wednesday that ezogabine (Potiga) is an effective adjunctive treatment for epilepsy patients with partial-onset seizures.
Read Full Article…
Possibly Related Blogs
FDA Advisors to Consider Epilepsy Drug
Posted on 10. Aug, 2010 by Dr. Ellis in News and Updates
(MedPage Today) — An FDA advisory committee will meet Wednesday to decide whether to recommend approval of ezogabine (Potiva) for adjunctive treatment of partial-onset seizures in epilepsy patients.
Read Full Article…
Possibly Related Blogs
FDA Panel Wants Tougher Restrictions on Opioids
Posted on 23. Jul, 2010 by Dr. Ellis in News and Updates
ADELPHI, Md. (MedPage Today) — An FDA advisory committee voted 25-10 to reject the agency’s proposed plan to prevent inappropriate prescribing, misuse, and abuse of extended-release opioid painkillers, saying the plan lacks the teeth to stem the “public health crisis” of opioid addiction, overdose, and death.
Read Full Article…
